Afolaranmi, G. and Tettey, J.N.A. and Murray, H.M. and Meek, R.M.D. and Grant, M.H. (2010) The effect of anticoagulants on the distribution of chromium VI in blood fractions relevance to patients with metal orthopedic implants. Journal of Arthroplasty, 25 (1). pp. 118-120. ISSN 1532-8406
This is the latest version of this item.
Metal-on-metal resurfacing arthroplasty is associated with elevated circulating levels of cobalt and chromium ions. To establish the long-term safety of metal-on-metal resurfacing arthroplasty, it has been recommended that during clinical follow-up of these patients, the levels of these metal ions in blood be monitored. In this article, we provide information on the distribution of chromium VI ions (the predominant form of chromium released by cobalt-chrome alloys in vivo and in vitro) in blood fractions. Chromium VI is predominantly partitioned into red blood cells compared with plasma (analysis of variance, P < .05). The extent of accumulation in red blood cells is influenced by the anticoagulant used to collect the blood, with EDTA giving a lower partitioning into red cells compared with sodium citrate and sodium heparin.
|Keywords:||hexavalent chromium, orthopedic implants, distribution in blood, anticoagulant, plasma, red blood cells, Bioengineering, Engineering (General). Civil engineering (General), Physiology, Orthopedics and Sports Medicine|
|Subjects:||Technology > Engineering (General). Civil engineering (General) > Bioengineering
Technology > Engineering (General). Civil engineering (General)
Science > Physiology
|Department:||Faculty of Engineering > Bioengineering
Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences
|Depositing user:||Ms Ashley Urie|
|Date Deposited:||26 Mar 2010 15:18|
|Last modified:||22 Mar 2017 10:54|
Available Versions of this Item
- The effect of anticoagulants on the distribution of chromium VI in blood fractions relevance to patients with metal orthopedic implants. (deposited 26 Mar 2010 15:18) [Currently Displayed]